Recalls and Warnings
(Date Posted: 4/14/2020)
|Teami Tea Settles Charges of Unproven Claims and Deceptive Celebrity Endorsements
On March 6, 2020, the FTC announced that Teami, LLC, a marketer of tea and skin care products, agreed to settle charges that it was selling products with unproven claims and misleading celebrity endorsements.
According to the FTC's complaint, the company claimed that its products, such as its "detox teas" and Teami 30 Day Detox Pack could "cause rapid and substantial weight loss, fight against cancerous cells, decrease migraines, unclog arteries, and prevent colds and flu." However, the FTC stated that these claims were not supported with reliable scientific evidence.
The claims were promoted with deceptive endorsements from ten celebrities: musicians Cardi B and Jordin Sparks; TV personalities Adrienne Bailon, Jenicka Lopez, Leyla Milani-Khoshbin, Darnell Nicole, and Alexa PenaVega; and social media influencers Katya Elise Henry, Princess Mae, and Brittany Renner. Each one posted to their social media about Teami products but failed to make clear that they had been paid to endorse the company. These ten celebrities have been warned by the FTC as well.
The proposed agreement bars Teami from making unsupported weight-loss and health claims. It also imposes a $15.2 million judgement, which reflects the total sales of the products subject in the complaint. However, this amount will be partially suspended once the defendents pay $1 million.
See ConsumerLab.com's Green Tea Review and Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
Federal Court Shuts Down Two Supplement Companies Selling Weight, Joint Health and Other Supplements
FTC Sends Refund Checks to Consumers of Unproven Weight-Loss Products
Marketers of CellAssure and Cognify Settle FTC Charges of Deceptive Cancer Claims
To read the FTC's news release, use the link below.
Tea Marketer Misled Consumers, Didn't Adequately Disclose Payments to Well-Known Influencers, FTC Alleges
For other Recalls and Warnings click HERE.
For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please go to http://www.fda.gov/medwatch/how.htm.